BIOLAB GENERIC
PRODUCT
CLOPIDOGREL 75 MG COMP REV X 30
BRIEF DESCRIPTION/INDICATION
"Clopidogrel bisulfate is indicated for the secondary prevention (after occurrence) of atherothrombotic events, such as acute myocardial infarction (MI) (heart attack), cerebrovascular accident (CVA) (stroke) and vascular death in adult patients who have had a recent MI or CVA or a condition known as peripheral arterial disease (disease in the blood vessels of the limbs).
PRESENTATION
Coated tablet
THERAPEUTIC CLASS
Antiplatelet agent
CLASSIFICATION
Sale on prescription
COMPOSITE
CLOPIDOGREL BISULFATE
See leaflet
IF SYMPTOMS PERSIST, THE DOCTOR SHOULD BE CONSULTED.